perfosfamide has been researched along with Acute Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, D; Carawan, H; Chao, NJ; Colvin, MO; Dodge, R; Gasparetto, C; Koh, LP; Loftis, J; Long, GD; Morris, A; Reese, M; Rizzieri, DA; Smith, CS; Talbot, JT; Vredenburgh, JJ; Waters-Pick, B | 1 |
| Braine, H; Colvin, M; Kaizer, H; Korbling, M; Santos, G; Saral, R; Stuart, R; Tutschka, P | 1 |
| Appelbaum, FR; Bensinger, WI; Buckner, CD; Demirer, T; Gooley, T; Lilleby, K; Petersen, FB; Rowley, S; Sanders, J; Storb, R | 1 |
| Rowley, SD | 1 |
| Ball, ED; Malley, V; Rubin, J | 1 |
| Damon, LE; Linker, CA; Ries, CA; Rugo, HS; Wolf, JL | 1 |
| Armitage, JO; Calderwood, S; Harris, RE; Horowitz, MM; Jones, RJ; Keating, A; Klein, JP; Lazarus, HM; Linker, CA; Miller, CB; Piantadosi, S; Rowlings, PA; Sobocinski, KA; Weisdorf, D; Zhang, MJ | 1 |
| Ambinder, RF; Braine, H; Brodsky, RA; Flinn, IW; Fuchs, EJ; Fuller, D; Gore, SD; Jones, RJ; Lee, SM; Miller, CB; Noga, SJ; O'Donnell, PV; Piantadosi, S; Smith, BD; Vala, MS; Vogelsang, GB | 1 |
| Jones, RJ | 1 |
| Bhalla, K; Bullock, G; Holladay, C; Ibrado, AM; Jasiok, M; Lutzky, J; Singh, S | 1 |
| Wiley, JM; Yeager, AM | 1 |
| Gorin, NC | 1 |
| Debusscher, L; Delforge, A; Loos, M; Rongé-Collard, E; Socquet, M; Stryckmans, P | 1 |
| Beschorner, WE; Braine, HG; Brookmeyer, R; Burns, WH; Fuller, DJ; Kaizer, H; Korbling, M; Mangan, KF; Saral, R; Stuart, RK | 1 |
1 review(s) available for perfosfamide and Acute Disease
| Article | Year |
|---|---|
Purging with 4-hydroperoxycyclophosphamide.
Topics: Acute Disease; Bone Marrow Purging; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclophosphamide; Humans; Leukemia; Lymphoma | 1992 |
2 trial(s) available for perfosfamide and Acute Disease
| Article | Year |
|---|---|
4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Humans; Leukemia, Myeloid; Leukocytes, Mononuclear; Male; Maximum Tolerated Dose; Middle Aged; Neoplastic Cells, Circulating; Peripheral Blood Stem Cell Transplantation; Remission Induction; Survival Analysis; Transplantation, Autologous | 2003 |
Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; In Vitro Techniques; Leukemia; Leukopenia; Male; Middle Aged; Postoperative Complications; Transplantation, Autologous | 1985 |
11 other study(ies) available for perfosfamide and Acute Disease
| Article | Year |
|---|---|
Autologous bone marrow transplantation in acute leukemia and non-Hodgkin's lymphoma: a phase I study of 4-hydroperoxycyclophosphamide (4HC) incubation of marrow prior to cryopreservation.
Topics: Acute Disease; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Drug Evaluation; Freezing; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Tissue Preservation | 1983 |
Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Cells; Bone Marrow Purging; Bone Marrow Transplantation; Cell Count; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Female; Graft Survival; Humans; Infant; Leukemia, Myeloid; Male; Middle Aged; Regression Analysis; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 1995 |
Bone marrow purging, 4-hydroperoxycyclophosphamide, and the FDA.
Topics: Acute Disease; Bone Marrow; Bone Marrow Purging; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Industry; Drug Utilization; Ethics, Medical; Humans; Leukemia, Myeloid; Multicenter Studies as Topic; Neoplasm, Residual; Treatment Outcome; United States; United States Food and Drug Administration | 1993 |
A combination of anti-CD15 monoclonal antibody PM-81 and 4-hydroperoxycyclophosphamide augments tumor cytotoxicity while sparing normal progenitor cells.
Topics: Acute Disease; Antibodies, Monoclonal; Bone Marrow Purging; Combined Modality Therapy; Cyclophosphamide; Cytotoxicity, Immunologic; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myeloid; Leukocytes, Mononuclear; Lewis X Antigen; Tumor Cells, Cultured | 1994 |
Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Middle Aged; Transplantation, Autologous | 1998 |
The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Americas; Bone Marrow Purging; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Female; Graft Survival; Humans; Infant; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Prognosis; Proportional Hazards Models; Registries; Remission Induction; Retrospective Studies; Risk; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2001 |
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Neutrophils; Prognosis; Recurrence; Remission Induction; Transplantation, Autologous | 2002 |
Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-mediated reduction of glutathione levels and cytotoxicity in normal and leukemic bone marrow progenitor cells.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cells, Cultured; Cyclophosphamide; Drug Interactions; Glutathione; Glutathione Transferase; Hematopoietic Stem Cells; Humans; Interleukin-3; Interleukin-6; Leukemia, Myeloid; Tumor Cells, Cultured | 1992 |
Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats.
Topics: Acute Disease; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Colony-Forming Units Assay; Cyclophosphamide; Female; Leukemia, Myeloid; Predictive Value of Tests; Rats; Stem Cells; Transplantation, Isogeneic | 1991 |
Autologous bone marrow transplantation in acute leukemia.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Bone Marrow Transplantation; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia; Magnetics; Neprilysin; Rabbits; Recurrence; Ricin; Transplantation, Autologous; Whole-Body Irradiation | 1986 |
Effect of 4-hydroperoxycyclophosphamide on leukemic and normal human myeloid progenitor cells.
Topics: Acute Disease; Bone Marrow; Cyclophosphamide; Dose-Response Relationship, Drug; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myeloid, Acute; Tumor Stem Cell Assay | 1985 |